The number of men dying from prostate cancer has overtaken female deaths from breast cancer for the first time in the UK, figures show. An ageing population means more men are developing and dying from the disease. Prostate Cancer UK says advances in the diagnosis and treatment of breast cancer are paying off, and increased funding could benefit prostate cancer. The biggest cancer killers in the UK remain lung and bowel cancer, with prostate now in third place. The latest figures from 2015 show there were 11,819 deaths from prostate cancer compared with 11,442 from breast cancer. //&! https://www.theguardian.com/commentisfree/2018/feb/05/men-dying-prostate-cancer-reason-gender-bias-daily-mail

(ask ask dean ornish and dr michael greger) Regular monitoring of men with localised prostate cancer offers them the same – higher than expected – survival chance after 10 years as surgery or radiotherapy, according to a major study.

Former Rolling Stones bassist Bill Wyman has been diagnosed with prostate cancer. A spokesman for the musician said: "He is undergoing treatment and is expected to make a full recovery as it was caught in the early stages."

diatary intervention in COPD patients. higher antioxidant intake = less oxidative stress = stopping or even reversing lung function decline. // people like to absolve themselves from their problems, 'I can't do anything about this.' - youtu.be/f1XDEHUf6yA - cancer, overweight, obesity, sedentary. // its the same saying you are not a racist and actually being an anti-racist. meaning you are going on the street, activism, talking about racism

[ lol, can't ask people to go whole-food plant-based and keep the alcohol, tobacco at a minimum - youtu.be/ECaI1XwonN0 + reversal of heart disease! - &! healthier lifestyle - bbc.in/1P6Gj1t &! bbc.in/1xwrVbA ] UK researchers are carrying out a trial to see if exercise therapy can help men with prostate cancer. The Sheffield Hallam University team, backed by Cancer Research UK, have a hunch that physical activity can help the body stop tumours from spreading. They are asking 50 men with prostate cancer that has not yet spread to put the theory to the test for 12 months. They hope to show that aerobic exercise is a treatment in its own right and should be offered on the NHS. Half of the men will have weekly supervised exercise sessions, while the other 25 will only be given information about the benefits of exercise for cancer patients.

A new gene therapy technique is able to modify prostate cancer cells so that a patient's body attacks and kills them, US scientists have discovered. The technique causes the tumour cells in the body to self-destruct, giving it the name 'suicide gene therapy'. Their research found a 20% improvement in survival in patients with prostate cancer five years after treatment. A cancer expert said more research was needed to judge its effectiveness. Prostate cancer is the most common cancer in men in the UK with more than 41,000 diagnosed each year.

[ public perception doesn't exist, about the horrors of cancer, chemo and radiotherapy, and invasive surgery that makes you incontinent and have no sex life anymore ] A blood test can determine whether prostate cancer patients are likely to respond to drugs, scientists say. Tests on 97 men, described in Science Translational Medicine, were able to tell whether tumours were already resistant to the drug abiraterone. [...] Abiraterone is a potent drug able to shrink tumours, but only some men benefit. [...] Cancers can evolve resistance to drugs over time, so the team of scientists set about looking for evidence in the fragments of tumour DNA that float in the blood stream.

[ end of life management. after extensive surgery failed, chemo failed, you are a broken man who needs adult pampers because of incontinence and wait for your last meal managing the spread of cancer with morphine. nobody talks about those extremes. something like this should get onto the packaging of bacon. ] A charity says a decision by the NHS in England to reject a drug for men with prostate cancer is a "fiasco". Abiraterone is already given to patients at the end-of-life after chemotherapy as it gives patients an extra few months. But the National Institute for Health and Care Excellence said it was not cost-effective to offer it earlier. It said while the drug improved quality of life, it was unclear whether it had the same impact on life expectancy. This was due to problems with the research data, NICE said, claiming the trial was finished early - something disputed by the drug's makers Janssen.

The scale of the challenge is apparent. I think we should be as bold and ambitious as possible: scientists, clinicians, patients, the general public and politicians all working together for a single goal: to eliminate cancer within a generation, and Britain at the forefront of this. [...] Patient experience has to be prioritised and this is difficult when NHS cancer services are under unprecedented pressure and the Government far too often provides contradictory messages. The Department of Health must provide the NHS with the resources and the long-term, holistic stability to allow Trusts to invest in state-of-the-art equipment. The NHS needs to emphasise prevention and early detection too, but the risk is that under greater financial and workforce pressure, cancer services will be forced to firefight.

One in two people in the UK will be diagnosed with cancer at some point in their lives, analysis suggests. Cancer Research UK said this estimate, using a new calculation method, replaced a forecast of more than one in three people developing the disease. It said longer life expectancies meant more people would be affected. But it was not inevitable and improving lifestyle, such as losing weight and quitting smoking, could have a major impact, the charity added. The good news is cancer survival figures are also rising. &! Cancer diagnosis rate of 1,000 per day to 'push NHS to limit' The NHS will be "pushed to its limit" by the end of 2016 by rising numbers of cancer patients, a charity says. [...] The Department of Health said it had invested £750m in cancer care. [...] "Cracks in the NHS are already beginning to show," - bbc.co.uk/news/health-30040451

Thousands of scientific papers have been published on the link between diet and the treatment and prevention of cancer. But in practice food is still considered a marginal aspect of cancer care. [...] "In the UK we don't have enough of those randomised studies to say that 'if you eat enough cabbage and broccoli and fruit juices and have some turmeric and maybe some wine and chocolate, yes this can be helpful, but it's not going to be enough to cure cancer'." [... >> yes but it delays the impact once cancer has when reached certain size, vegan diet slows cancerous cell proliferation, ... you should die of old age, not of cancer.] [...] Our research confirmed that in most cancer centres in the UK, diet is still seen as almost meaningless in cancer treatment and aftercare. ["Let thy food be your medicine." is a long-term approach ... being Vegan.] [...] [T]here is no financial incentive.

Perhaps the biggest misconception is that as long as you lose weight, it doesn’t matter what you eat. But it does. Yet being thin and being healthy are not at all the same thing. Being overweight is not necessarily linked with disease or premature death. What you eat affects which diseases you may develop, regardless of whether you’re thin or fat. Some diets that may help you lose weight may be harmful to your health over time.

Vegan Diet + Regular Exercise + Stress Management = risisng probability of Good Health into old age (dying of age, not bc of a disease).

Bloomberg's Shannon Pettypiece reports on Johnson & Johnson's Zytiga, the first prostate cancer pill to win U.S. marketing approval in a family of treatments that offer new ways to stymie the male hormones that fuel tumor growth. Similar medicines from Medivation Inc. and Takeda Pharmaceutical Co. will report study results this weekend at the American Society of Clinical Oncology meeting in Chicago. Pettypiece speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)

They add that only about 1 in 7 men with newly diagnosed prostate cancer are at risk for a serious form of the disease. “Out of 50,000 radical prostatectomies performed every year in the United States alone,” Dr. Scholz writes, “more than 40,000 are unnecessary. In other words, the vast majority of men with prostate cancer would have lived just as long without any operation at all. Most did not need to have their sexuality cut out.”

Yet radical prostatectomy is still the treatment recommended most often, even though a recent study in The New England Journal of Medicine suggested that it extended the lives of just 1 patient in 48.

In my experience, doctors play down punishing side effects like incontinence, impotence and shrinking of the penis. Those are just words when you hear them, but beyond language when you go through them.